Due to its strong cytostatic ability, TGFβ is a potent tumour suppressor, and several members of TGFβ signalling pathway are frequently mutated in human cancers including colon and pancreatic cancer [8, 9]. This evidence concerns the gene TGFB1 and neoplasm.